The European Medicine Evaluation Agency (EMEA) is a decentralised body of the European Union with headquarters in London.
EMEA’s main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.
The EMEA is divided in different Committees. The most relevant for human health is the Committee for Medicinal Products for Human Use (CHMP). Giving the importance of this committee, EMEA decided to set up a working group with patients’ groups. Members of this working group are mainly patients’ groups (most of them funded by the pharmaceutical industry), a consumer organisation (BEUC), EPHA and the European AIDS Treatment Group (EATG), an EPHA member.
EPHA was represented by Emmanuel Trenado, from AIDES, an EPHA member, in the working group meetings of 2004.
You can find the reports and background documents of the 2004 meetings below.
October 2004 meeting
Please find below a copy of each of the annexes of the "Recommendations and Proposal for Action" document that were discused in the meeting plus the introductory document to the meeting.
Both versions of each annex are attached, i.e. draft and revised - each has been revised as per the discussions during the October meeting (note: for Annex 4 both are in one document).
Minutes of the 29 Otober meeting of the Working Group with patients’ organisations.
December 2004 meeting
Next meeting is scheduled for the 3 December 2004. Please find below information regarding the documents for the December meeting:
Morning session:
Agenda
The revised "Policy on involvement of Patients’ and Consumers’ Organisations in EMEA Activities" document, including comments from the "Committee for Orphan Medicinal Products" and the "Committee on Herbal Medicinal Products", and which will be submitted to the EMEA Management Board shortly.
The revised "Mandate and Rules of Procedure" of the group, for discussion.
Afternoon workshop:
Agenda
The "Recommendations and Proposal for Action" document, with all comments shown
The "Recommendations and Proposal for Action" document, revised according to comments and discussions (individual comments not shown)
